| abstract |
The present invention relates to stimulators of soluble guanylate cyclase (sGC), pharmaceutical formulations containing them, and uses thereof, for use alone or in combination with one or more other agents for the treatment of various diseases, which may be desired The ones in which the concentration of nitric oxide (NO) is increased and/or the concentration of cyclic guanosine monophosphate (cGMP) is increased. Various compounds are disclosed, including those of formula (I). |